NVWM LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $815K | Buy |
4,824
+4,064
| +535% | +$695K | 0.18% | 138 |
|
|
2025
Q4 | $128K | Hold |
760
| – | – | 0.03% | 206 |
|
|
2025
Q3 | $110K | Hold |
760
| – | – | 0.02% | 216 |
|
|
2025
Q2 | $96.1K | Hold |
760
| – | – | 0.02% | 222 |
|
|
2025
Q1 | $97.2K | Sell |
760
-733
| -49% | -$99.4K | 0.03% | 211 |
|
|
2024
Q4 | $197K | Buy |
1,493
+733
| +96% | +$103K | 0.05% | 197 |
|
|
2024
Q3 | $111K | Sell |
760
-12
| -2% | -$1.74K | 0.03% | 214 |
|
|
2024
Q2 | $106K | Hold |
772
| – | – | 0.03% | 213 |
|
|
2024
Q1 | $106K | Hold |
772
| – | – | 0.03% | 207 |
|
|
2023
Q4 | $105K | Hold |
772
| – | – | 0.03% | 207 |
|
|
2023
Q3 | $94.4K | Hold |
772
| – | – | 0.03% | 206 |
|
|
2023
Q2 | $98K | Hold |
772
| – | – | 0.03% | 213 |
|
|
2023
Q1 | $99.7K | Sell |
772
-8,823
| -92% | -$1.15M | 0.03% | 216 |
|
|
2022
Q4 | $1.26M | Sell |
9,595
-841
| -8% | -$109K | 0.46% | 65 |
|
|
2022
Q3 | $1.22M | Buy |
10,436
+8,852
| +559% | +$1.1M | 0.48% | 65 |
|
|
2022
Q2 | $187K | Hold |
1,584
| – | – | 0.07% | 180 |
|
|
2022
Q1 | $206K | Sell |
1,584
-19
| -1% | -$2.48K | 0.07% | 186 |
|
|
2021
Q4 | $245K | Hold |
1,603
| – | – | 0.08% | 181 |
|
|
2021
Q3 | $259K | Hold |
1,603
| – | – | 0.09% | 185 |
|
|
2021
Q2 | $262K | Hold |
1,603
| – | – | 0.09% | 181 |
|
|
2021
Q1 | $241K | Sell |
1,603
-5,910
| -79% | -$939K | 0.1% | 176 |
|
|
2020
Q4 | $1.14M | Buy |
7,513
+423
| +6% | +$60.5K | 0.47% | 65 |
|
|
2020
Q3 | $960K | Buy |
7,090
+239
| +3% | +$32.4K | 0.45% | 69 |
|
|
2020
Q2 | $937K | Buy |
6,851
+5,768
| +533% | +$735K | 0.5% | 61 |
|
|
2020
Q1 | $117K | Sell |
1,083
-318
| -23% | -$36.6K | 0.08% | 143 |
|
|
2019
Q4 | $169K | Hold |
1,401
| – | – | 0.1% | 143 |
|
|
2019
Q3 | $139K | Sell |
1,401
-192
| -12% | -$20.1K | 0.09% | 154 |
|
|
2019
Q2 | $174K | Hold |
1,593
| – | – | 0.1% | 160 |
|
|
2019
Q1 | $178K | Hold |
1,593
| – | – | 0.12% | 147 |
|
|
2018
Q4 | $154K | Sell |
1,593
-126
| -7% | -$13.4K | 0.12% | 142 |
|
|
2018
Q3 | $210K | Sell |
1,719
-834
| -33% | -$98.2K | 0.13% | 143 |
|
|
2018
Q2 | $280K | Sell |
2,553
-147
| -5% | -$15.7K | 0.19% | 132 |
|
|
2018
Q1 | $277K | Sell |
2,700
-9,333
| -78% | -$1.03M | 0.2% | 132 |
|
|
2017
Q4 | $1.28M | Buy |
+12,033
| New | +$1.29M | 0.98% | 26 |
|
Other funds holding IBB
CB
NVWM LLC's IBB Position: Q1 2026 in Review
NVWM LLC increased its iShares Biotechnology ETF (IBB) stake by 535% in Q1 2026, buying an estimated $695K and bringing the position to 4,824 shares worth $815K. The position accounts for 0.18% of the portfolio, ranked #138.
NVWM LLC first reported a position in IBB in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.28M in Q4 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- NVWM LLC held 4,824 shares of iShares Biotechnology ETF worth $815K as of Q1 2026.
- NVWM LLC bought 4,064 iShares Biotechnology ETF shares in Q1 2026, an estimated $695K.
- iShares Biotechnology ETF made up 0.18% of NVWM LLC's portfolio in Q1 2026, its #138 holding.
- NVWM LLC first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 34 quarters since.
- NVWM LLC's iShares Biotechnology ETF position peaked at $1.28M in Q4 2017.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.